US4474768A
(en)
*
|
1982-07-19 |
1984-10-02 |
Pfizer Inc. |
N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
|
ZA835204B
(en)
*
|
1982-07-19 |
1985-02-27 |
Pfizer |
N-methyl 11-aza-10-deoxo-10-dihydroerythromycin a,intermediates therefor and processes for their preparation
|
US4526889A
(en)
*
|
1982-11-15 |
1985-07-02 |
Pfizer Inc. |
Epimeric azahomoerythromycin A derivative, intermediates and method of use
|
PH19293A
(en)
*
|
1982-11-15 |
1986-03-04 |
Pfizer |
Epimeric azahomoerythromycin,pharmaceutical composition containing the same and method of use thereof
|
JPS59225198A
(ja)
*
|
1983-05-23 |
1984-12-18 |
フアイザ−・インコ−ポレ−テツド |
抗菌性を有する9―デオキソ―9a―アザ―9a―ホモエリスロマイシンA,その製造方法および組成物
|
EP0132026B1
(de)
*
|
1983-05-23 |
1986-12-30 |
Pfizer Inc. |
Cyclische Ether, mit antibakterieller Wirkung, von 9-Deoxy-9a-Aza-9a-Homoerythromycin und Zwischenprodukte
|
US4492688A
(en)
*
|
1983-11-25 |
1985-01-08 |
Pfizer Inc. |
Antibacterial cyclic ethers of 9-deoxo-9a-aza-9a-homoerythromycin A and intermediates therefor
|
US4464527A
(en)
*
|
1983-06-30 |
1984-08-07 |
Pfizer Inc. |
Antibacterial 9-deoxo-9a-alkyl-9a-aza-9a-homoerythromycin A derivatives and intermediates therefore
|
US4465674A
(en)
*
|
1983-09-06 |
1984-08-14 |
Pfizer Inc. |
Azahomoerythromycin D derivative and intermediates therefor
|
DE3475073D1
(en)
*
|
1983-09-06 |
1988-12-15 |
Pfizer |
Azahomoerythromycin b derivatives and intermediates thereof
|
US4512982A
(en)
*
|
1984-04-13 |
1985-04-23 |
Pfizer Inc. |
9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
|
US4518590A
(en)
*
|
1984-04-13 |
1985-05-21 |
Pfizer Inc. |
9α-Aza-9α-homoerythromycin compounds, pharmaceutical compositions and therapeutic method
|
US4921947A
(en)
*
|
1986-03-31 |
1990-05-01 |
Eli Lilly And Company |
Process for preparing macrolide derivatives
|
WO1989000576A1
(en)
|
1987-07-09 |
1989-01-26 |
Pfizer Inc. |
Azithromycin dihydrate
|
WO1989002271A1
(en)
*
|
1987-09-10 |
1989-03-23 |
Pfizer |
Azithromycin and derivatives as antiprotozoal agents
|
HRP20020231A2
(en)
*
|
2002-03-18 |
2003-12-31 |
Pliva D D |
ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
|
US6017894A
(en)
*
|
1988-08-03 |
2000-01-25 |
Schering Corporation |
Actinomadura fulva subsp uruguayensis and antimicrobial complex and antimicrobial compounds isolated therefrom
|
YU45590A
(sh)
*
|
1990-03-07 |
1992-07-20 |
PLIVA FARMACEVTSKA, KEMIJSKA, PREHRAMBENA I KOZMETIČKA INDUSTRIJA s.p.o. |
Novi kompleksi odnosno helati antibiotika s dvovalentnim i/ili trovalentnim metalima i postupci za njihovo dobijanje
|
US5912331A
(en)
*
|
1991-03-15 |
1999-06-15 |
Merck & Co., Inc. |
Process for the preparation of 9-deoxo-9(Z)-hydroxyiminoerythromycin A
|
US5985844A
(en)
*
|
1992-03-26 |
1999-11-16 |
Merck & Co., Inc. |
Homoerythromycin A derivatives modified at the 4"-and 8A-positions
|
US5189159A
(en)
*
|
1992-04-02 |
1993-02-23 |
Merck & Co., Inc. |
8a-AZA-8a-homoerythromycin cyclic iminoethers
|
US5215980A
(en)
*
|
1992-01-17 |
1993-06-01 |
Merck & Co., Inc. |
10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives thereof
|
TW271400B
(de)
*
|
1992-07-30 |
1996-03-01 |
Pfizer |
|
US5210235A
(en)
*
|
1992-08-26 |
1993-05-11 |
Merck & Co., Inc. |
Methods of elaborating erythromycin fragments into amine-containing fragments of azalide antibiotics
|
US5332807A
(en)
*
|
1993-04-14 |
1994-07-26 |
Merck & Co., Inc. |
Process of producing 8A- and 9A-azalide antibiotics
|
ATE154806T1
(de)
*
|
1993-05-19 |
1997-07-15 |
Pfizer |
Zwischenprodukt für azithromycin
|
US5441939A
(en)
*
|
1994-03-04 |
1995-08-15 |
Pfizer Inc. |
3"-desmethoxy derivatives of erythromycin and azithromycin
|
AU687555B2
(en)
*
|
1994-04-26 |
1998-02-26 |
Nobuhiro Narita |
Medicinal composition as a remedy for non-small cell lung cancer
|
US5605889A
(en)
*
|
1994-04-29 |
1997-02-25 |
Pfizer Inc. |
Method of administering azithromycin
|
KR100232297B1
(ko)
*
|
1994-05-06 |
1999-12-01 |
디. 제이. 우드 |
아지트로마이신의 제어된 방출 투여형 제제
|
ES2122905B1
(es)
*
|
1996-07-11 |
1999-11-16 |
Astur Pharma Sa |
Sintesis de 11,12-hidrogenoortoborato de 9-desoxo-9a-aza-11,12-desoxi-9a-metil-9a-homoeritromicina a. un procedimiento para la preparacion de 9-desoxo-9a-aza-9a-metil-9a-homoeritromicina a dihidrato (azitromicina dihidrato).
|
PT102006B
(pt)
*
|
1997-05-19 |
2000-06-30 |
Hovione Sociedade Quimica S A |
Novo processo de preparacao de azitromicina
|
HN1998000074A
(es)
*
|
1997-06-11 |
1999-01-08 |
Pfizer Prod Inc |
Derivados de macrolidos c-4 sustituidos
|
HN1998000086A
(es)
*
|
1997-06-11 |
1999-03-08 |
Pfizer Prod Inc |
Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
|
JP2003512290A
(ja)
*
|
1997-09-10 |
2003-04-02 |
メルク エンド カムパニー インコーポレーテッド |
家畜抗菌剤としての8a−アザライド
|
KR100554549B1
(ko)
*
|
1997-10-16 |
2006-03-03 |
플리바 파마세우츠카 인두스트리야, 디오닉코, 드러스트보 |
9a-아잘리드류로부터 유래한 신규한 3,6-헤미케탈
|
AP1060A
(en)
|
1998-01-02 |
2002-04-23 |
Pfizer Prod Inc |
Novel erythromycin derivatives.
|
HRP980189B1
(en)
*
|
1998-04-06 |
2004-04-30 |
Pliva Pharm & Chem Works |
Novel 15-membered lactams ketolides
|
TW546302B
(en)
|
1998-05-08 |
2003-08-11 |
Biochemie Sa |
Improvements in macrolide production
|
EP1437360A3
(de)
*
|
1998-08-19 |
2005-04-06 |
Pfizer Products Inc. |
C11-Carbamate von antibakteriellen Makroliden
|
US6043227A
(en)
*
|
1998-08-19 |
2000-03-28 |
Pfizer Inc. |
C11 carbamates of macrolide antibacterials
|
CA2245398C
(en)
*
|
1998-08-21 |
2002-01-29 |
Apotex Inc. |
Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
|
AU5299499A
(en)
|
1998-09-22 |
2000-04-10 |
Pfizer Products Inc. |
Carbamate and carbazate ketolide antibiotics
|
EE200100245A
(et)
*
|
1998-11-03 |
2002-10-15 |
Pfizer Products Inc. |
Uued makroliidsed antibiootikumid
|
UA70972C2
(uk)
*
|
1998-11-20 |
2004-11-15 |
Пфайзер Продактс Інк. |
13-членні азаліди і їх застосування як антибіотиків
|
CN1273142C
(zh)
|
1998-11-30 |
2006-09-06 |
特瓦制药工业有限公司 |
阿齐霉素的乙醇化物,制备方法以及医药组合物
|
WO2000034297A1
(en)
|
1998-12-10 |
2000-06-15 |
Pfizer Products Inc. |
Carbamate and carbazate ketolide antibiotics
|
JP3947360B2
(ja)
*
|
1999-01-27 |
2007-07-18 |
ファイザー・プロダクツ・インク |
ケトリド抗生物質
|
US6239113B1
(en)
|
1999-03-31 |
2001-05-29 |
Insite Vision, Incorporated |
Topical treatment or prevention of ocular infections
|
US7056893B2
(en)
|
1999-03-31 |
2006-06-06 |
Insite Vision, Inc. |
Topical treatment for prevention of ocular infections
|
EE200100613A
(et)
*
|
1999-05-24 |
2003-02-17 |
Pfizer Products Inc. |
13-metüülerütromütsiini derivaadid
|
US6465437B1
(en)
*
|
1999-06-30 |
2002-10-15 |
Pfizer Inc. |
Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
|
US6764996B1
(en)
|
1999-08-24 |
2004-07-20 |
Abbott Laboratories |
9a-azalides with antibacterial activity
|
EP1101769A3
(de)
|
1999-11-18 |
2001-10-24 |
Pfizer Products Inc. |
Stickstoff-enthaltend Erythromycin-Derivate
|
ES2177373B1
(es)
*
|
1999-11-26 |
2003-11-01 |
Astur Pharma Sa |
Preparacion de azitromicina en su forma no cristalina
|
IL150564A0
(en)
|
2000-01-04 |
2003-02-12 |
Teva Pharma |
Preparation method of azithromycin dihydrate
|
IL141438A0
(en)
*
|
2000-02-23 |
2002-03-10 |
Pfizer Prod Inc |
Method of increasing the bioavailability and tissue penetration of azithromycin
|
US6544555B2
(en)
|
2000-02-24 |
2003-04-08 |
Advancis Pharmaceutical Corp. |
Antibiotic product, use and formulation thereof
|
US6565882B2
(en)
|
2000-02-24 |
2003-05-20 |
Advancis Pharmaceutical Corp |
Antibiotic composition with inhibitor
|
DE10030781A1
(de)
*
|
2000-06-29 |
2002-01-17 |
Hassan Jomaa |
Kombinationspräparate von 3-N-Formylhydroxylaminopropylphosphonsäurederivaten oder 3-N-Acetylhydroxylaminopropylphosphonsäurederivaten mit spezielen pharmazeutischen Wirkstoffen
|
US6403776B1
(en)
|
2000-07-05 |
2002-06-11 |
Pfizer Inc. |
Synthesis of carbamate ketolide antibiotics
|
ATE320441T1
(de)
|
2000-07-25 |
2006-04-15 |
Silanes Sa De Cv Lab |
Einstufiges verfahren zur herstellung von 7,16-
|
US20020115621A1
(en)
*
|
2000-08-07 |
2002-08-22 |
Wei-Gu Su |
Macrolide antibiotics
|
CA2419873A1
(en)
*
|
2000-08-23 |
2002-02-28 |
Wockhardt Limited |
Process for preparation of anhydrous azithromycin
|
US6541014B2
(en)
|
2000-10-13 |
2003-04-01 |
Advancis Pharmaceutical Corp. |
Antiviral product, use and formulation thereof
|
US20020068078A1
(en)
|
2000-10-13 |
2002-06-06 |
Rudnic Edward M. |
Antifungal product, use and formulation thereof
|
KR100815163B1
(ko)
|
2000-11-27 |
2008-03-19 |
바이오케미 에스.에이. |
마크로라이드 용매화물
|
US20020197314A1
(en)
*
|
2001-02-23 |
2002-12-26 |
Rudnic Edward M. |
Anti-fungal composition
|
JP4104463B2
(ja)
|
2001-04-27 |
2008-06-18 |
ファイザー・プロダクツ・インク |
4’’−置換された−9−デオキソ−9a−アザ−9a−ホモエリスロマイシン誘導体を製造するための方法
|
HRP20010301A2
(en)
*
|
2001-04-27 |
2001-12-31 |
Pliva D D |
New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases
|
EP1671979B1
(de)
|
2001-05-22 |
2008-08-13 |
Pfizer Products Inc. |
Neue Kristallforme von Azithromycin
|
US6861413B2
(en)
*
|
2001-05-22 |
2005-03-01 |
Pfizer Inc. |
Stable non-dihydrate azithromycin oral suspensions
|
ATE319730T1
(de)
*
|
2001-05-22 |
2006-03-15 |
Pfizer Prod Inc |
Neue kristallforme von azithromycin
|
YU8804A
(sh)
*
|
2001-08-21 |
2006-08-17 |
Pfizer Products Inc. |
Jedno-dozni azitromicin
|
AU2002335087A1
(en)
*
|
2001-10-18 |
2003-04-28 |
Teva Pharmaceutical Industries Ltd. |
Stabilized azithromycin compositions
|
US20080149521A9
(en)
*
|
2001-10-18 |
2008-06-26 |
Michael Pesachovich |
Methods of stabilizing azithromycin
|
US7182915B2
(en)
*
|
2001-11-30 |
2007-02-27 |
Bristol-Myers Squibb Company |
Pipette configurations and arrays thereof for measuring cellular electrical properties
|
AU2003219770B2
(en)
|
2002-02-15 |
2008-10-09 |
Merckle Gmbh |
Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
|
WO2003070254A1
(en)
*
|
2002-02-15 |
2003-08-28 |
Sympore Gmbh |
Antibiotic conjugates
|
US20040186063A1
(en)
*
|
2002-02-15 |
2004-09-23 |
Hans-Jurgen Gutke |
Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
|
AU2003215245A1
(en)
*
|
2002-02-15 |
2003-09-09 |
Sympore Gmbh |
Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
|
EP1490090A4
(de)
|
2002-02-22 |
2006-09-20 |
New River Pharmaceuticals Inc |
Wirkstoff-abgabesystem und verfahren zum schutz und zur verabreichung von wirkstoffen
|
WO2003072589A1
(fr)
*
|
2002-02-26 |
2003-09-04 |
Meiji Seika Kaisha, Ltd. |
Nouveau compose azalide cyclique a 15 chainons, nouveau derive diazalide cyclique a 16 chainons et procede de production de ceux-ci
|
ITMI20021209A1
(it)
*
|
2002-06-04 |
2003-12-04 |
Chemi Spa |
Processo di preparazione di azitromicina ad elevata purezza
|
US20040043073A1
(en)
*
|
2002-06-14 |
2004-03-04 |
Chih-Ming Chen |
Pharmaceutical compositions for drugs having pH-dependent solubility
|
US6855813B2
(en)
*
|
2002-07-19 |
2005-02-15 |
Alembic Limited |
Process for the preparation of azithromycin monohydrate
|
HRP20020614A2
(en)
*
|
2002-07-22 |
2004-06-30 |
PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. |
Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
|
ITMI20022292A1
(it)
|
2002-10-29 |
2004-04-30 |
Zambon Spa |
9a-azalidi ad attivita' antiinfiammatoria.
|
US7670627B2
(en)
*
|
2002-12-09 |
2010-03-02 |
Salvona Ip Llc |
pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients
|
US20040266997A1
(en)
*
|
2003-03-25 |
2004-12-30 |
Michael Pesachovich |
Degradation products of azithromycin, and methods for their indentification
|
US6645941B1
(en)
*
|
2003-03-26 |
2003-11-11 |
Enanta Pharmaceuticals, Inc. |
6,11-3C-bicyclic 9a-azalide derivatives
|
ES2220229B1
(es)
*
|
2003-05-29 |
2005-10-16 |
Quimica Sintetica, S.A. |
Sales de adicion de azitromicina y acido citrico y procedimiento para su obtencion.
|
CA2675724C
(en)
*
|
2003-06-16 |
2012-12-04 |
Andrx Pharmaceuticals, Llc |
Oral extended-release composition
|
GB2395482A
(en)
*
|
2003-07-03 |
2004-05-26 |
Jubilant Organosys Ltd |
Process for preparing non-hygroscopic azithromycin dihydrate
|
US8313775B2
(en)
|
2003-07-21 |
2012-11-20 |
Shionogi Inc. |
Antibiotic product, use and formulation thereof
|
CA2533358C
(en)
|
2003-07-21 |
2014-03-11 |
Advancis Pharmaceutical Corporation |
Antibiotic product, use and formulation thereof
|
CA2533178C
(en)
|
2003-07-21 |
2014-03-11 |
Advancis Pharmaceutical Corporation |
Antibiotic product, use and formulation thereof
|
CA2535177A1
(en)
|
2003-08-11 |
2005-02-24 |
Advancis Pharmaceutical Corporation |
Robust pellet
|
US8062672B2
(en)
|
2003-08-12 |
2011-11-22 |
Shionogi Inc. |
Antibiotic product, use and formulation thereof
|
JPWO2005019238A1
(ja)
*
|
2003-08-22 |
2006-10-19 |
明治製菓株式会社 |
新規アザライド及びアザラクタム誘導体とその製造法
|
AU2004270170B2
(en)
|
2003-08-29 |
2011-01-27 |
Shionogi, Inc. |
Antibiotic product, use and formulation thereof
|
US8460710B2
(en)
|
2003-09-15 |
2013-06-11 |
Shionogi, Inc. |
Antibiotic product, use and formulation thereof
|
US7276487B2
(en)
*
|
2003-09-23 |
2007-10-02 |
Enanta Pharmaceuticals, Inc. |
9a, 11-3C-bicyclic 9a-azalide derivatives
|
US20050101547A1
(en)
*
|
2003-11-06 |
2005-05-12 |
Sadatrezaei Mohsen |
Stabilized azithromycin composition
|
US6984403B2
(en)
*
|
2003-12-04 |
2006-01-10 |
Pfizer Inc. |
Azithromycin dosage forms with reduced side effects
|
BRPI0417338A
(pt)
*
|
2003-12-04 |
2007-04-17 |
Pfizer Prod Inc |
formas de dosagem de azitromicina multiparticulada por processos a base de lìquido
|
WO2005053652A1
(en)
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
|
WO2005053639A2
(en)
*
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Controlled release multiparticulates formed with dissolution enhancers
|
JP2007513145A
(ja)
*
|
2003-12-04 |
2007-05-24 |
ファイザー・プロダクツ・インク |
医薬用多微粒子の製造方法
|
WO2005053656A1
(en)
*
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Spray-congeal process using an extruder for preparing multiparticulate crystalline drug compositions containing preferably a poloxamer and a glyceride
|
WO2005053651A1
(en)
*
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Multiparticulate compositions with improved stability
|
WO2005053653A1
(en)
*
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Spray-congeal process using an extruder for preparing multiparticulate azithromycin compositions containing preferably a poloxamer and a glyceride
|
US7943585B2
(en)
|
2003-12-22 |
2011-05-17 |
Sandoz, Inc. |
Extended release antibiotic composition
|
US20060116336A1
(en)
*
|
2004-03-17 |
2006-06-01 |
American Pharmaceutical Partners, Inc. |
Lyophilized azithromycin formulation
|
US7468428B2
(en)
*
|
2004-03-17 |
2008-12-23 |
App Pharmaceuticals, Llc |
Lyophilized azithromycin formulation
|
WO2006011160A1
(en)
*
|
2004-06-28 |
2006-02-02 |
Alembic Limited |
Process for the preparation of azithromycin monohydrate isopropanol clathrate
|
US8715727B2
(en)
|
2004-07-02 |
2014-05-06 |
Shionogi Inc. |
Tablet for pulsed delivery
|
EP1782816B1
(de)
*
|
2004-07-02 |
2011-10-19 |
Wakamoto Pharmaceutical Co., Ltd. |
Medizinische zusammensetzung auf wasserbasis mit azithromycin und herstellungsverfahren dafür
|
US7683162B2
(en)
*
|
2004-08-30 |
2010-03-23 |
Taro Pharmaceutical Industries Limited |
Process of preparing a crystalline azithromycin monohydrate
|
US20060046970A1
(en)
*
|
2004-08-31 |
2006-03-02 |
Insite Vision Incorporated |
Topical otic compositions and methods of topical treatment of prevention of otic infections
|
SI1836211T1
(sl)
|
2004-12-21 |
2010-04-30 |
Pfizer Prod Inc |
Makrolidi
|
US8524735B2
(en)
|
2005-05-18 |
2013-09-03 |
Mpex Pharmaceuticals, Inc. |
Aerosolized fluoroquinolones and uses thereof
|
RU2008106915A
(ru)
*
|
2005-07-26 |
2009-09-10 |
Меркле Гмбх (De) |
Макролидные конъюгаты пирролиновых и индолизиновых соединений
|
US8778924B2
(en)
|
2006-12-04 |
2014-07-15 |
Shionogi Inc. |
Modified release amoxicillin products
|
US8357394B2
(en)
|
2005-12-08 |
2013-01-22 |
Shionogi Inc. |
Compositions and methods for improved efficacy of penicillin-type antibiotics
|
EP1985620A4
(de)
*
|
2006-02-07 |
2012-08-15 |
Taisho Pharmaceutical Co Ltd |
10a-AZALIDVERBINDUNG
|
US8299052B2
(en)
*
|
2006-05-05 |
2012-10-30 |
Shionogi Inc. |
Pharmaceutical compositions and methods for improved bacterial eradication
|
CA2661538A1
(en)
|
2006-08-24 |
2008-02-28 |
Wockhardt Research Centre |
Novel macrolides and ketolides having antimicrobial activity
|
US7704959B2
(en)
|
2006-10-03 |
2010-04-27 |
Dow Pharmaceutical Sciences |
Azithromycin for the treatment of nodular acne
|
WO2009019868A1
(ja)
|
2007-08-06 |
2009-02-12 |
Taisho Pharmaceutical Co., Ltd. |
10a、12位架橋型10a-アザライド化合物
|
US20090062220A1
(en)
*
|
2007-08-29 |
2009-03-05 |
Protia, Llc |
Deuterium-enriched azithromycin
|
US8299035B2
(en)
*
|
2008-05-15 |
2012-10-30 |
Taisho Pharmaceutucal Co., Ltd. |
10a-azalide compound having 4-membered ring structure
|
US8629139B2
(en)
|
2008-10-07 |
2014-01-14 |
Mpex Pharmaceuticals, Inc. |
Topical use of Levofloxacin for reducing lung inflammation
|
CA2739897C
(en)
|
2008-10-07 |
2017-10-03 |
Mpex Pharmaceuticals, Inc. |
Aerosol fluoroquinolone formulations for improved pharmacokinetics
|
US20170128481A9
(en)
|
2009-03-06 |
2017-05-11 |
Insite Vision Corporation |
Ocular treatment with reduced intraocular pressure
|
WO2011015219A1
(en)
|
2009-08-06 |
2011-02-10 |
Shifa Pharmed Industrial Group Co. |
Process for the purification of azithromycin by separation from its thermal degradation products and/or isomers
|
BR112012004692B8
(pt)
|
2009-09-04 |
2021-05-25 |
Mpex Pharmaceuticals Inc |
solução que compreende levofloxacina para uso em um método para tratar a fibrose cística em um ser humano
|
WO2012076989A1
(en)
|
2010-12-09 |
2012-06-14 |
Wockhardt Limited |
Ketolide compounds
|
AR085286A1
(es)
|
2011-02-21 |
2013-09-18 |
Taisho Pharmaceutical Co Ltd |
Derivado de macrolido sustituido en la posicion c-4
|
KR101567658B1
(ko)
|
2011-03-01 |
2015-11-09 |
욱크하르트 리미티드 |
케톨리드 중간체의 제조 방법
|
CA2830861C
(en)
|
2011-03-22 |
2017-01-24 |
Wockhardt Limited |
Process for preparation of ketolide compounds
|
WO2013088274A1
(en)
|
2011-12-14 |
2013-06-20 |
Wockhardt Limited |
Anhydrous amorphous azithromycin composition free of azithromycin dihydrate
|
KR20150098675A
(ko)
|
2012-12-24 |
2015-08-28 |
라모트 앳 텔-아비브 유니버시티 리미티드 |
넌센스 돌연변이로부터 생긴 유전적 질환을 치료하기 위한 물질 및 이를 확인하는 방법
|
US9044508B2
(en)
|
2013-03-15 |
2015-06-02 |
Insite Vision Corporation |
Concentrated aqueous azalide formulations
|
US20150141328A1
(en)
*
|
2013-11-18 |
2015-05-21 |
The Schepens Eye Research Institute |
Stimulation of human meibomian gland function
|
AR102810A1
(es)
|
2014-08-18 |
2017-03-29 |
Taisho Pharmaceutical Co Ltd |
Derivado de macrólido sustituido en la posición c-4
|
CN104910222B
(zh)
*
|
2015-06-29 |
2018-02-13 |
石药集团欧意药业有限公司 |
阿奇霉素新晶型化合物及其制备方法
|
CN105061528B
(zh)
*
|
2015-08-05 |
2017-10-17 |
浙江维康药业股份有限公司 |
一种阿奇霉素化合物及含有该化合物的阿奇霉素软胶囊
|
US20230218644A1
(en)
|
2020-04-16 |
2023-07-13 |
Som Innovation Biotech, S.A. |
Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus
|